Facebook
Twitter
Telegram
Report an ErrorCatalyst Pharmaceuticals Financial Ratios 2011-2024 | CPRX
Annual Financial Ratios Catalyst Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
21.9 | 17.8 | 15.1 | 5.0 | 13.5 | -7.5 | -16.2 | -5.0 | -7.4 | -15.1 | -7.4 | -4.0 | -3.7 |
P/S |
3.9 | 6.9 | 4.2 | 3.2 | 4.2 | 507.0 | - | - | - | - | - | - | - |
EPS |
0.7 | 0.8 | 0.4 | 0.7 | 0.3 | -0.3 | -0.2 | -0.2 | -0.2 | -0.2 | -0.3 | -0.1 | -0.3 |
EV (Enterprise Value) |
1.51 B | 1.25 B | 455 M | 269 M | 367 M | 247 M | 246 M | 78.8 M | 127 M | 234 M | 92.2 M | 17 M | 20.1 M |
EBITDA per Share |
0.82 | 0.99 | 0.51 | 0.4 | 0.312 | -0.344 | -0.217 | -0.232 | -0.252 | -0.227 | -0.226 | -0.173 | -0.278 |
EV/EBITDA |
7.2 | 5.9 | 10.6 | -6.7 | -12.9 | -4.0 | -6.0 | -15.4 | -8.6 | -2.8 | -2.9 | ||
PEG |
-1.88 | 5.18 | -0.9 | -0.21 | 0.07 | 0.13 | -3.57 | -0.42 | 1.78 | -1.36 | 0.08 | -0.08 | 0.12 |
P/B |
4.0 | 4.9 | 2.9 | 2.2 | 4.9 | 5.0 | 3.7 | 2.3 | 2.7 | 6.6 | 4.2 | 1.1 | 6.3 |
P/CF |
10.9 | 12.7 | 9.9 | 8.4 | 12.5 | -9.8 | -21.7 | -5.0 | -8.3 | -18.0 | -9.2 | -3.1 | -4.7 |
ROE % |
18.41 | 27.65 | 19.09 | 44.21 | 36.37 | -66.96 | -22.74 | -45.98 | -36.47 | -44.01 | -56.82 | -27.88 | -169.94 |
ROA % |
15.19 | 22.12 | 16.60 | 38.98 | 28.36 | -56.25 | -21.56 | -43.33 | -33.66 | -35.32 | -47.91 | -24.28 | -102.27 |
ROCE % |
22.38 | 33.90 | 25.33 | 24.35 | 36.05 | -69.29 | -23.03 | -48.67 | -36.00 | -38.34 | -44.39 | -34.48 | -112.31 |
Current Ratio |
5.7 | 5.0 | 7.7 | 8.5 | 4.6 | 5.8 | 20.0 | 19.8 | 17.4 | 7.5 | 11.8 | 10.2 | 7.5 |
DSO |
29.3 | 14.5 | 16.3 | 25.3 | 37.6 | - | - | - | - | - | - | - | - |
DIO |
78.8 | 77.9 | 104.4 | 70.8 | 48.4 | - | - | - | - | - | - | - | - |
DPO |
65.9 | 35.8 | 58.6 | 89.7 | 101.8 | - | - | - | - | - | - | - | - |
Operating Cycle |
108.2 | 92.4 | 120.8 | 96.1 | 86.0 | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
42.2 | 56.6 | 62.2 | 6.4 | -15.8 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Catalyst Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.2 | - | -0.29 | 0.36 | 0.28 | - | 0.22 | 0.21 | 0.13 | - | 0.1 | 0.12 | 0.07 | - | 0.42 | 0.09 | 0.1 | 0.08 | 0.13 | 0.11 | -0.01 | -0.14 | -0.08 | -0.06 | -0.06 | -0.06 | -0.05 | -0.05 | -0.06 | -0.05 | -0.05 | -0.06 | -0.07 | -0.07 | -0.05 | -0.06 | -0.07 | -0.05 | -0.07 | -0.05 | -0.07 | -0.03 | -0.13 | -0.08 | -0.04 | - | -0.08 | -0.01 | -0.04 | -0.1 | -0.05 | -0.06 | -0.08 |
EBITDA per Share |
0.23 | - | - | - | 0.34 | - | 0.24 | 0.28 | 0.17 | - | 0.14 | 0.15 | 0.1 | - | 0.11 | 0.1 | 0.1 | 0.08 | 0.13 | 0.11 | -0.01 | -0.14 | -0.08 | -0.06 | -0.06 | -0.05 | -0.05 | -0.05 | -0.06 | -0.05 | -0.05 | -0.06 | -0.08 | -0.07 | -0.06 | -0.06 | -0.06 | -0.06 | -0.06 | -0.05 | -0.06 | -0.05 | -0.07 | -0.06 | -0.04 | -0.04 | -0.04 | -0.04 | -0.06 | -0.08 | -0.05 | -0.06 | -0.06 |
ROE % |
-3.44 | 10.10 | 18.52 | 35.77 | 34.68 | 23.40 | 28.60 | 25.38 | 22.86 | 15.94 | 41.49 | 61.85 | 61.17 | 37.47 | 46.52 | 36.52 | 43.26 | 36.37 | -1.23 | -32.22 | -56.47 | -66.96 | -45.06 | -34.78 | -27.83 | -22.74 | -26.68 | -31.58 | -38.41 | -45.98 | -45.87 | -43.83 | -40.42 | -36.47 | -35.89 | -42.09 | -42.95 | -44.01 | -40.44 | -53.86 | -59.48 | -56.82 | -51.01 | -41.30 | -28.58 | -27.88 | -89.89 | -101.96 | -137.05 | -169.94 | -29.99 | -37.07 | -40.34 |
ROA % |
-2.78 | 8.32 | 15.15 | 29.43 | 29.01 | 20.28 | 24.90 | 22.70 | 20.44 | 14.34 | 36.87 | 54.77 | 54.03 | 33.04 | 40.09 | 29.69 | 34.36 | 28.36 | -2.68 | -27.77 | -47.40 | -56.25 | -38.57 | -30.50 | -25.18 | -21.56 | -25.24 | -29.82 | -36.23 | -43.33 | -43.03 | -40.95 | -37.58 | -33.66 | -31.94 | -35.94 | -35.64 | -35.32 | -32.71 | -44.61 | -49.71 | -47.91 | -43.03 | -35.34 | -24.67 | -24.28 | -61.46 | -63.89 | -84.48 | -102.27 | -18.05 | -22.31 | -24.28 |
ROCE % |
-4.06 | 12.45 | 21.74 | 41.71 | 41.11 | 29.03 | 36.08 | 33.83 | 30.37 | 20.92 | 27.82 | 27.67 | 25.35 | 19.27 | 28.41 | 37.31 | 43.75 | 36.32 | -2.05 | -33.96 | -58.94 | -69.50 | -47.08 | -36.29 | -28.98 | -23.07 | -27.24 | -31.88 | -38.96 | -49.05 | -49.23 | -48.32 | -44.90 | -36.77 | -36.91 | -39.53 | -39.18 | -41.40 | -42.75 | -46.27 | -50.19 | -48.21 | -45.85 | -39.45 | -34.35 | -35.71 | -79.51 | -100.80 | -130.66 | -161.73 | -30.07 | -37.16 | -40.40 |
Current Ratio |
7.6 | 5.7 | 6.4 | 6.5 | 5.5 | 5.0 | 5.3 | 10.2 | 9.2 | 7.7 | 9.1 | 10.4 | 10.6 | 8.4 | 8.4 | 8.4 | 8.4 | 4.5 | 4.5 | 4.5 | 4.5 | 6.2 | 6.2 | 6.2 | 6.2 | 19.3 | 19.3 | 19.3 | 19.3 | 17.4 | 17.4 | 17.4 | 17.4 | 13.0 | 13.0 | 13.0 | 13.0 | 5.1 | 5.1 | 5.1 | 5.1 | 6.4 | 6.4 | 6.4 | 6.4 | 7.8 | 7.8 | 7.8 | 7.8 | 2.5 | 2.5 | 2.5 | 2.5 |
DSO |
52.8 | - | 40.4 | 34.9 | 23.4 | - | 15.1 | 17.3 | 18.2 | - | 16.4 | 14.9 | 17.5 | - | 18.6 | 18.4 | 25.9 | 31.9 | 31.1 | 33.3 | 38.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
129.7 | - | 63.7 | 79.8 | 78.6 | - | 70.7 | 93.6 | 121.6 | - | 120.7 | 115.3 | 88.1 | - | 109.4 | 102.5 | 72.6 | - | 40.7 | 41.9 | 53.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
91.3 | - | 29.1 | 29.6 | 33.8 | - | 22.9 | 44.5 | 61.2 | - | 48.8 | 55.1 | 66.4 | - | 100.1 | 93.8 | 92.0 | - | 85.6 | 88.2 | 172.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
182.5 | - | 104.1 | 114.8 | 102.0 | - | 85.8 | 110.9 | 139.8 | - | 137.1 | 130.2 | 105.6 | - | 128.0 | 121.0 | 98.5 | 31.9 | 71.8 | 75.2 | 92.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
91.2 | - | 75.0 | 85.2 | 68.2 | - | 62.9 | 66.4 | 78.5 | - | 88.3 | 75.2 | 39.2 | - | 27.9 | 27.1 | 6.5 | 31.9 | -13.8 | -12.9 | -79.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency